An approach for assessing effectiveness of a vaccination campaign against pertussis among young adults: The example of the French armed forces (2007-2012)

Journal of Infection

Volumn 68, Issue 4, 2014, Pages 395-397

  Sicard, Sébastien ^a   Berger, Franck ^a,b   Migliani, René ^a   Deparis, Xavier ^a,b   Michel, Rémy ^a,b   Mayet, Aurélie ^a,b  

^a French Army Center for Epidemiology and Public Health (CESPA)   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADOLESCENT; ADULT; ARMY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COUGHING; FEMALE; FRANCE; HUMAN; INCIDENCE; LABORATORY TEST; LETTER; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; POLYMERASE CHAIN REACTION; SEROLOGY; SOLDIER; VACCINATION;

ADOLESCENT; ADULT; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; FRANCE; HAEMOPHILUS VACCINES; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MILITARY PERSONNEL; TREATMENT OUTCOME; WHOOPING COUGH; YOUNG ADULT;

EID: 84895919915     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.11.015     Document Type: Letter

References (10)

1. Mayet A., Brossier C., Haus-Cheymol R., Pommier de Santi V., Verret C., Decam C., et al. Results of pertussis surveillance in French military forces, 2007-2009: increasing reported incidence among young adults. J Infect 2011, 62:322-324.
2. Chiappini E., Stival A., Galli L., de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis 2013, 13:151.
3. Mayet A., Haus-Cheymol R., Bouaiti E.A., Decam C., Simon F., Mérens A., et al. Adverse events following vaccination in the french armed forces: an overview of surveillance conducted from 2002 to 2010. Eurosurveillance 2012, 17. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20193.
4. Calendrier vaccinal 2008-avis du haut conseil de la santé publique. Bull Epidemiol Heb 2008, 17:1-20.
5. World Health Organization. WHO-recommended surveillance standard of pertussis. [accessed 16.10.13]. http://www.who.int/immunization_monitoring/diseases/pertussis_surveillance/en/index.html.
6. Guiso N. Biological diagnosis of whooping cough. J Pediatr Pueric 2003, 16:365-368. [in French].
7. Berger F., Njamkepo E., Minaberry S., Mayet A., Haus-Cheymol R., Verret C., et al. Investigation of a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy. Vaccine 2010, 12:5147-5152.
8. Baxter R., Bartlett J., Rowhani-Rahbar A., Fireman B., Klein N.P. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ 2013 Jul 17, 347:f4249. 10.1136/bmj.f4249.
9. Rank C., Quinn H.E., McIntyre P.B. Pertussis vaccine effectiveness after mass immunization of high school students in Australia. Pediatr Infect Dis J 2009, 28:152-153.
10. Klein N.P., Bartlett J., Rowhani-Rahbar A., Fireman B., Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012 Sep 13, 367(11):1012-1019.